Study of RO7515629 in Participants With HLA-G Positive Solid Tumors
Ontology highlight
ABSTRACT: The main purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, immune response and preliminary anti-tumor activity of RO7515629 alone in participants with advanced or metastatic solid tumors expressing human leukocyte antigen G (HLA-G).
DISEASE(S): Adenocarcinoma,Pancreatic Adenocarcinoma,Non-small Cell Lung Cancer,Colorectal Cancer,Colorectal Neoplasms,Carcinoma, Renal Cell,Carcinoma, Non-small-cell Lung,Ovarian Neoplasms,Renal Cell Carcinoma
PROVIDER: 11560 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA